Role of ENHERTU in Management of Breast Cancer

Authors

  • Febby A Tembo Department of Pharmaceutical Sciences, School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India
  • Navneet Khurana Department of Pharmaceutical Sciences, School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India
  • Neha Sharma Department of Pharmaceutical Sciences, School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India

DOI:

https://doi.org/10.21276/apjhs.2021.8.4S.2

Keywords:

Breast Cancer, ENHERTU, HER2 protein, Hormone therapy.

Abstract

Being a lady is the most significant hazard factor for creating breast cancer. Men too can get it however in uncommon and rare conditions. Several risk factors can in danger the lives of breast cancer patients. Over the years the treatment of breast cancer was dependent upon chemotherapy, radiation, hormone therapy, and surgery which of course is still being done as a way of reducing the effects and controlling its spread to other parts of the body. As this disease is incurable several drugs have been developed over time to reduce the effects and spread of it. In this article, we are focused on a newly developed drug known as ENHERTU to be used in treating breast cancer. Few methods are used in the detection of breast cancer to determine its treatment. As a result, a total number of 234 patients were treated with the newly developed drug under the clinical trials to study the workings and effectiveness of the drug. In conclusion, the results of the drug proved to be positive to treat breast cancer before its approval by the Food and Drug Administration.

Downloads

Download data is not yet available.

Downloads

Published

2021-12-31

How to Cite

Febby A Tembo, Navneet Khurana, & Neha Sharma. (2021). Role of ENHERTU in Management of Breast Cancer. Asian Pacific Journal of Health Sciences, 8(4), 6–10. https://doi.org/10.21276/apjhs.2021.8.4S.2

Issue

Vol. 8 No. 4 (2021): Vol 8 Issue 4 October-December(S) 2021

Section

Articles

License

Copyright (c) 2022 Febby A Tembo, Navneet Khurana, Neha Sharma

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Asian Pacific Journal of Health Sciences applies the Creative Commons Attribution (CC-BY) license to published articles. Under this license, authors retain ownership of the copyright for their content, but they allow anyone to download, reuse, reprint, modify, distribute and/or copy the content as long as the original authors and source are cited. Appropriate attribution can be provided by simply citing the original article.